Treatment of genetic screening of hypertriglyceridemia type I, III, and V - HTG Amsterdam

ABSTRACT:

This is a cohort of patients with extreme hypertriglyceridemia. Patients have been screened for loss of function mutations in LPL, GPIHBP1, APOC2, APOA5 and LMF1.

PROVIDER: phs000511.v1.p1 | EGA |

REPOSITORIES: EGA